From $49.99/mo · Free consult · 4.2★ on Trustpilot · All 50 States
814 verified reviews
Affordable multi-medication hair-loss platform with dutasteride access from board-certified physicians — competitive entry pricing with broader catalog than mass-market.
Complete the Maximus hair-loss intake — onset timing, family history, current Norwood stage, prior finasteride exposure, current medications, and medication preference (finasteride / dutasteride / minoxidil / combination). Free physician consult; most prescriptions written within 24–48 hours.
First medication shipment lands within 3–5 days of script approval (free priority shipping). Start with the prescribed protocol — typically oral finasteride 1mg daily as first-line, or dutasteride 0.5mg daily for patients indicated for the stronger DHT inhibitor. Initial shedding phase begins in weeks 2–8 (normal turnover, not treatment failure).
First reasonable check-in point. Shedding phase usually subsides by month 2–3. The advantage of Maximus's board-certified-MD model: titration conversations and protocol questions get handled by the same prescriber relationship vs rotating async support tickets at high-volume mass-market alternatives.
Real response window for finasteride or dutasteride. Photo comparisons against baseline typically show stabilization or modest regrowth in responders. For finasteride non-responders, Maximus's catalog includes dutasteride as the next-step protocol within the same prescriber relationship — vs mass-market subscription telehealth that often refers out for dutasteride. Adding minoxidil for combination response remains an option throughout.
[Hims](/online-providers/hair-loss/hims) is the category-leading entry-priced finasteride at $22/mo basic monotherapy — narrowly cheaper than Maximus $24.99/mo entry. Maximus's edge: dutasteride access within the catalog (Hims declines), board-certified physician specialty credential, and multi-medication catalog integration. For basic finasteride monotherapy at absolute lowest cost, Hims wins by $3/mo. For users interested in dutasteride or wanting board-certified-MD specialty over algorithmic intake, Maximus differentiates. AHF rates Hims 4.0 and Maximus 4.1 (hair-loss) — narrow gap reflects Maximus's catalog breadth + clinical-specialty advantages over Hims's category-leading entry price.
[PeterMD](/online-providers/hair-loss/petermd) is the mass-market subscription telehealth at $60/mo basic finasteride plus the ReGenX bundle for combination therapy. Maximus is the affordable multi-medication catalog at $24.99/mo entry with dutasteride access and board-certified-MD specialty. Maximus undercuts PeterMD significantly on basic finasteride pricing (~$35/mo cheaper) and adds dutasteride availability that PeterMD doesn't carry. PeterMD's edge: established operating-history track record and the proprietary ReGenX combination bundle for users wanting more than monotherapy. AHF rates PeterMD 3.9 and Maximus 4.1 (hair-loss).
Yes — Maximus's hair-loss line operates with board-certified physicians specializing in men's health, dispensing FDA-approved finasteride, dutasteride (off-label for hair loss), and minoxidil through FDA-registered pharmacies. The same legitimacy infrastructure as their TRT and ED operations. The 814+ Trustpilot reviews at 4.2 rating give a meaningful operating-history track record. Free priority shipping across all medications is standard.
Free consultation. Independently reviewed. Board-certified physicians.
Get Free ConsultationSecure telemedicine · HIPAA compliant · Cancel anytime